Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin infusion during haemodialysis in end-stage renal failure
ACTRN12609000543280Phase 4Completed
- Sponsor
- University of Otago
- Start
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human insulin in end-stage kidney disease (ESKD) and chronic kidney disease (CKD) (2 arms), sponsored by University of Otago. Primary endpoints: Change in highly sensitive C-reactive protein, Inflammatory cytokines and 1 more. Started Aug 2008; status: completed.
02
Drugs
human insulin
03
Conditions
end-stage kidney disease (ESKD)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12609000543280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000543280.